摘要
将人类免疫缺陷病毒(HIV)感染者与同年龄的健康人进行比较,人类免疫缺陷病毒(HIV)感染者有更高的患病感染率。复杂的艾滋病毒引起的免疫抑制,慢性抗原刺激,以及致癌病毒共同感染之间的关系,可能会促进肿瘤的发生,并增加这些患者肿瘤发展的风险。艾滋病感染者的癌症包括艾滋病定义恶性肿瘤(ADMS)和其他非艾滋病定义恶性肿瘤(NADMs)。抗逆转录病毒疗法减少了ADMs 的发病率,在过去几年中观察到,同时增加了NADMs的发生率。生物标志物是可测量的参数,表征了正常或致病的过程,它具有高潜能去进行患者的风险评估和诊断。因此,艾滋病毒阳性患者的癌症生物标志物早期检测将十分有用以确定患者在大多数肿瘤疾病发展中的风险。本次审查将重点集中于艾滋病的恶性肿瘤生物标志物上,细胞和病毒生物标志物,包括细胞因子,免疫激活分子和遗传多态性的几个生物标志物的风险评估和诊断的作用。
关键词: 艾滋病恶性肿瘤;肿瘤标志物;癌症艾滋病病毒;霍奇金淋巴瘤;非艾滋病恶性肿瘤;非霍奇金淋巴瘤。
Current Medicinal Chemistry
Title:The Role of Cancer Biomarkers in HIV Infected Hosts
Volume: 23 Issue: 22
Author(s): Domenico Galati, Serena Zanotta
Affiliation:
关键词: 艾滋病恶性肿瘤;肿瘤标志物;癌症艾滋病病毒;霍奇金淋巴瘤;非艾滋病恶性肿瘤;非霍奇金淋巴瘤。
摘要: A higher incidence of cancer has been observed in Human Immunodeficiency Virus (HIV) infected individuals as compared with healthy people of the same age. A complex relationship between HIV-induced immune suppression, chronic antigenic stimulation, and oncogenic virus co-infections may promote carcinogenesis and increase the risk of developing tumors in these patients. Cancers in HIV subjects include the AIDS-defining malignancies (ADMs) and other non-AIDS-defining malignancies (NADMs). Antiretroviral therapy has reduced the incidence of ADMs whereas a concurrent increase of NADMs was observed in the last years. Biomarkers are measurable parameters, characterizing normal or pathogenic processes, which could provide a high potential for risk evaluation and diagnosis of patients. Therefore, the early detection of cancer biomarkers in HIV-positive subjects would be useful to identify patients at most risk of tumor disease development.
This review will focus principally on the risk assessment and diagnostic role of several biomarkers of malignancy in HIV patients including cellular and viral biomarkers, cytokines, immune activation molecules and genetic polymorphisms.
Export Options
About this article
Cite this article as:
Domenico Galati, Serena Zanotta , The Role of Cancer Biomarkers in HIV Infected Hosts, Current Medicinal Chemistry 2016; 23 (22) . https://dx.doi.org/10.2174/0929867323666160530145102
DOI https://dx.doi.org/10.2174/0929867323666160530145102 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of C-Reactive Protein in Atherosclerotic Cardiovascular Disease: An Overview
Current Vascular Pharmacology Autoimmune Neuromuscular Disorders
Current Neuropharmacology Effects and Role of Multikinase Inhibitors in Thyroid Cancer
Current Pharmaceutical Design Aptamers as Innovative Diagnostic and Therapeutic Agents in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Repositioning the Old Fungicide Ciclopirox for New Medical Uses
Current Pharmaceutical Design Cancer-Related Fatigue: Still an Enigma to be Solved Quickly
Reviews on Recent Clinical Trials Drugs that Inhibit Tubulin Polymerization: The Particular Case of Podophyllotoxin and Analogues
Current Medicinal Chemistry - Anti-Cancer Agents Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options
Current Neuropharmacology Modified Envelope Glycoproteins to Retarget Retroviral Vectors
Current Gene Therapy Subject Index To Volume 8
Current Pharmaceutical Design The Development of Targeted Therapies for Hepatocellular Cancer
Current Pharmaceutical Design Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Current Cancer Drug Targets Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Current Pharmaceutical Design Oxidative Stress in the Cochlea: An Update
Current Medicinal Chemistry The Disulfide Analogues of Isophosphoramide Mustard for Anticancer Therapy
Letters in Drug Design & Discovery Recent Advancements in 1,4-Disubstituted 1H-1,2,3-Triazoles as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Immune Restoration Disease: A Consequence of Dysregulated Immune Responses After HAART
Current HIV Research Brain Delivery of Chemotherapeutics in Brain Cancer
Anti-Cancer Agents in Medicinal Chemistry Different Aspects of Head and Neck Squamous Cell Carcinoma: Cancer Stem Cells, their Niche and Targeted Therapy
Current Stem Cell Research & Therapy Angiogenesis: A Target for Cancer Therapy
Current Pharmaceutical Design